Goldman Sachs’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.8K | Sell |
26,871
-231,235
| -90% | -$627K | ﹤0.01% | 4937 |
|
|
2025
Q1 | $875K | Buy |
258,106
+113,261
| +78% | +$384K | ﹤0.01% | 3907 |
|
|
2024
Q4 | $597K | Buy |
+144,845
| New | +$597K | ﹤0.01% | 4200 |
|
|
2017
Q3 | – | Sell |
-719
| Closed | -$76K | – | 4303 |
|
|
2017
Q2 | $76K | Buy |
719
+622
| +641% | +$65.7K | ﹤0.01% | 4189 |
|
|
2017
Q1 | $13K | Sell |
97
-288
| -75% | -$38.6K | ﹤0.01% | 4353 |
|
|
2016
Q4 | $61K | Buy |
385
+253
| +192% | +$40.1K | ﹤0.01% | 4204 |
|
|
2016
Q3 | $33K | Sell |
132
-28
| -18% | -$7K | ﹤0.01% | 4375 |
|
|
2016
Q2 | $143K | Buy |
160
+40
| +33% | +$35.8K | ﹤0.01% | 3998 |
|
|
2016
Q1 | $109K | Buy |
120
+17
| +17% | +$15.4K | ﹤0.01% | 4007 |
|
|
2015
Q4 | $146K | Buy |
103
+27
| +36% | +$38.3K | ﹤0.01% | 3858 |
|
|
2015
Q3 | $128K | Buy |
76
+1
| +1% | +$1.68K | ﹤0.01% | 4058 |
|
|
2015
Q2 | $162K | Sell |
75
-17
| -18% | -$36.7K | ﹤0.01% | 4118 |
|
|
2015
Q1 | $169K | Sell |
92
-130
| -59% | -$239K | ﹤0.01% | 3964 |
|
|
2014
Q4 | $530K | Buy |
+222
| New | +$530K | ﹤0.01% | 3334 |
|